PubRank

Andrés Redondo

Author PubWeight™ 16.99‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Angiogenesis and ovarian cancer. Clin Transl Oncol 2009 2.09
2 The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients. Endocr Relat Cancer 2010 1.73
3 Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis. Carcinogenesis 2005 1.44
4 An 8-gene qRT-PCR-based gene expression score that has prognostic value in early breast cancer. BMC Cancer 2010 1.34
5 Implications of oxidative stress and cell membrane lipid peroxidation in human cancer (Spain). Cancer Causes Control 2004 1.13
6 Aurora kinases as prognostic biomarkers in ovarian carcinoma. Hum Pathol 2009 0.97
7 Clinical role of Sm-153 EDTMP in the treatment of painful bone metastatic disease. Clin Nucl Med 2006 0.95
8 Targeting the endothelin axis in prostate carcinoma. Tumour Biol 2011 0.90
9 Comparison of prognostic gene profiles using qRT-PCR in paraffin samples: a retrospective study in patients with early breast cancer. PLoS One 2009 0.86
10 Role of surgery in patients with recurrent, metastatic, or unresectable locally advanced gastrointestinal stromal tumors sensitive to imatinib: a retrospective analysis of the Spanish Group for Research on Sarcoma (GEIS). Ann Surg Oncol 2015 0.85
11 Angiogenesis as a therapeutic target in urothelial carcinoma. Anticancer Drugs 2010 0.82
12 Angiogenesis-related gene expression profile with independent prognostic value in advanced ovarian carcinoma. PLoS One 2008 0.82
13 High-throughput techniques in breast cancer: a clinical perspective. Eur J Cancer 2006 0.82
14 Feasibility of a modified outpatient regimen of intravenous/intraperitoneal chemotherapy in optimally debulked stage III ovarian cancer patients: a GEICO study. Int J Gynecol Cancer 2011 0.80
15 Gene profiling in breast cancer: time to move forward. Cancer Treat Rev 2011 0.79
16 NIS mediates iodide uptake in the female reproductive tract and is a poor prognostic factor in ovarian cancer. J Clin Endocrinol Metab 2014 0.76
17 Meningeal relapse by follicular lymphoma as a single mass. Clin Transl Oncol 2008 0.75
18 From targeted therapy in ovarian cancer to personalizing therapy for ovarian cancer. Expert Opin Investig Drugs 2011 0.75